PEG Ratio: 1.43
Is the PEG ratio high or low?
The PEG ratio of 1.43 is 35% below its 5-year average of 2.20, near the low end of its 5-year range (0.17–6.99).
66.03% below its 12-month average of 4.21.
DGX PEG Ratio Chart
Reported annual fiscal-period values; no daily interpolation.
DGX Average PEG Ratio Chart
DGX Current vs Average PEG Ratio Chart
DGX PEG Ratio Metrics
PEG RATIO
1.43
PEG RATIO AVG TTM
4.21
PEG RATIO AVG 3Y
4.21
PEG RATIO AVG 5Y
2.20
PEG RATIO AVG 10Y
1.57
PEG RATIO AVG 15Y
1.51
PEG RATIO AVG 20Y
0.96
CURRENT VS TTM AVG
-66.03%
CURRENT VS 3Y AVG
-66.03%
CURRENT VS 5Y AVG
-35.07%
CURRENT VS 10Y AVG
-9.08%
CURRENT VS 15Y AVG
-5.42%
CURRENT VS 20Y AVG
+49.20%
DGX Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $22.83B | 1.43 | 4.21 | 4.21 | 2.20 |
| BioNTech SE (BNTX)vs › | $22.76B | N/A | 0.23 | 0.12 | 0.12 |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 1.16 | 0.84 | 0.59 | 0.59 |
| Moderna, Inc. (MRNA)vs › | $23.71B | N/A | 0.18 | 0.14 | 0.14 |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 1.28 | 0.79 | 0.79 | 0.47 |
| Incyte Corporation (INCY)vs › | $21.48B | 0.72 | 0.00 | 0.16 | 0.24 |
| Waters Corporation (WAT)vs › | $24.57B | 75.61 | 75.61 | 40.77 | 27.51 |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 8.96 | 5.67 | 4.53 | 3.90 |
| STERIS plc (STE)vs › | $20.52B | 1.03 | 0.80 | 0.61 | 0.61 |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 1.42 | 1.47 | 5.65 | 5.88 |
Growth-Adjusted Valuation
PEG Ratio
1.43
P/E Ratio
22.8
PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
PEG Ratio FAQ
- What is the PEG ratio for Quest Diagnostics Incorporated (DGX)?
- The PEG ratio for DGX stock is 1.43.
- Is Quest Diagnostics Incorporated's PEG ratio high or low?
- The PEG ratio of 1.43 is 35% below its 5-year average of 2.20, near the low end of its 5-year range (0.17–6.99).
- What is the TTM average PEG ratio for Quest Diagnostics Incorporated (DGX)?
- The TTM average PEG ratio for DGX stock is 4.21.
- What is the 3Y average PEG ratio for Quest Diagnostics Incorporated (DGX)?
- The 3Y average PEG ratio for DGX stock is 4.21.
- What is the 5Y average PEG ratio for Quest Diagnostics Incorporated (DGX)?
- The 5Y average PEG ratio for DGX stock is 2.20.
- What is the 10Y average PEG ratio for Quest Diagnostics Incorporated (DGX)?
- The 10Y average PEG ratio for DGX stock is 1.57.
- What is the 15Y average PEG ratio for Quest Diagnostics Incorporated (DGX)?
- The 15Y average PEG ratio for DGX stock is 1.51.
- What is the 20Y average PEG ratio for Quest Diagnostics Incorporated (DGX)?
- The 20Y average PEG ratio for DGX stock is 0.96.
DGX PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2025-12-31 | 1.43 |
| 2024-12-31 | 6.99 |
| 2021-12-31 | 0.22 |
| 2020-12-31 | 0.17 |
| 2019-12-31 | 0.93 |
| 2017-12-31 | 0.76 |
| 2015-12-31 | 0.51 |
| 2013-12-31 | 0.16 |
| 2012-12-31 | 0.91 |
| 2010-12-31 | 3.04 |
| 2009-12-31 | 0.50 |
| 2008-12-31 | 0.25 |
| 2006-12-31 | 1.79 |
| 2005-12-31 | 1.79 |
| 2004-12-31 | 1.21 |
| 2003-12-31 | 0.66 |
| 2002-12-31 | 0.19 |
| 2001-12-31 | 0.78 |
| 1999-12-31 | 2.76 |
| 1997-12-31 | 0.23 |
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis